Early Access — free while we kick the tires
EdgarHawk

Donoghoe Nicholas

EVP, CHIEF BUS/STRAT OFFICER

Officer
1 filing analyzed · 1 company · Latest 2025-08-07

Companies

Company Buys Sells Direction
AbbVie Inc. ABBV 0 2 Net selling

Activity

August 2025
2025-08-07 AbbVie Inc. ABBV
medium
Sell
13,295 shares
$2,639,253
Significance 5/10

EVP Nicholas Donoghoe sold 13,295 shares at blended $198.51; reduces stake by 18.6% to 58,247 shares

On 2025-08-05, Nicholas Donoghoe, EVP and Chief Business/Strategy Officer, executed 2 separate sales totaling 13,295 shares for $2,639,252.88 at a blended average price of $198.51. This represents an 18.6% reduction of his holdings from 71,542 to 58,247 shares. The current stock price of $198.86 is within striking distance of the transaction prices ($198.27 and $198.59), suggesting the sales occurred near recent price levels. Donoghoe's cross-ticker track record shows 1 prior sell with a 90-day well-timed rate of 100.00%, and at ABBV specifically, his March 2024 sale showed -2.8% 90-day return—both instances where the stock fell after his sales. While the multi-transaction structure and magnitude of this sale warrant monitoring, the stock's +4.8% 30-day performance since the August 5 transaction date and the company's solid revenue base ($15,423,000,000 quarterly) provide context that this is a material but not extraordinary move by a senior strategic officer.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access